An experimental study on drugs for improving blood circulation and removing blood stasis in treating mild chronic hepatic damage.

Large and small doses of drugs for improving blood circulation and removing blood stasis were used in model rats to treat mild chronic hepatic damage induced by carbon tetrachloride (CCl4). The results show that large dose of Dang Gui ([symbol: see text] Radix Angelicae Sinensis) and Dan Shen ([symbol: see text] Radix Salviae Miltiorrhizae) (drugs for regulating blood flow) and small dose of Yu Jin ([symbol: see text] Radix Curcumae) and Niu Xi ([symbol: see text] Radix Achyranthis Bidentatae) (drugs for activating blood flow) can significantly elevate the activity of SOD (P < 0.05) and/or lower the T/K ratio, markedly reduce the MDA content (P < 0.05 or P < 0.01) and significantly decrease the activities of ALT and AST (P < 0.05 or P < 0.01), demonstrating that these drugs are effective in combating oxygen free radicals (OFR) in chronic liver damage. On the contrary, large dose of Tu Bie Chong ([symbol: see text] Eupolyphaga seu Steleophaga) and E Zhu ([symbol: see text] Rhizoma Curcumae) (drugs for removing blood stasis) tend to increase the ALT and AST (P < 0.05) activities. The results suggest that the synergism of elevation of the SOD activity and reduction of T/K ratio contributes to the action of drugs for improving blood circulation and removing blood stasis in combating the liver damage induced by CCl4.     

The regulatory action of Radix Astragali on M-cholinergic receptor of the brain of senile rats.

The changes in density of M-cholinergic receptors in different areas of senile rats and the regulatory action of Huang Qi ([symbol: see text] Radix Astragali, a drug for warming yang and replenishing qi) were observed by autoradiography. The results showed that the gray scale displayed in brain sections was clear and mainly distributed in the cortex, hippocampus and striate body, while that due to nonspecific combination was negligible. The gray scale in the cortex, hippocampus and striate body of the experimental group was markedly lower than that in the young control rats, decreased respectively by 24.87%, 14.12% and 12.76% (all P < 0.05); but it was obviously higher than those in the senile control rats, increased respectively by 24.15%, 14.38% and 13.47% (P < 0.05). The data indicate that Huang Qi ([symbol: see text]Radix Astragali) may up-regulate the decreased density of M-cholinergic receptors in the brain of senile rats.     

Treatment of the Localized Neurodermatitis by Plum-blossom Needle Tapping and with the Modified Yangxue Dingfeng Tang——A Clinical Observation of 47 Cases

Since 1993, the authors have successfully treated 47 cases of the localized neurodermatitis by plum-blossom needle tapping and with the modified Yangxue Dingfeng Tang, with quite good therapeutic results reported as follows. Clinical Data The 141 patients…     

TCM Treatment of Bronchial Asthma

Xuan Fei Ding Chuan Wan(宣肺定喘丸 pills for facilitating the flow of the lung-qi to relieve asthma)and Xiao Chuan Gu Ben Wan (哮喘固本丸 pills for treating asthma by consolidating the origin)wereused for treatment of bronchial asthma.The cure rate in the treated group(n=600)was 81.33%,significantly higher(P<0.01)than that in the control group(n=164,with a cure rate of 9.76%).     

Clinical observation of Chinese drugs in prevention of neonatal hyperbilirubinemia.

Observation of the preventive and curative effects of Herba Artemisiae Scopariae [symbol: see text], Fructus Gardeniae [symbol: see text], Radix Scutellariae [symbol: see text] and Radix et Rhizoma Rhei Preparata [symbol: see text] in 30 cases of neonatal hyperbilirubinemia showed that both the peak value of serum total bilirubin and the incidence of hyperbilirubinemia were obviously lower than that in the control group.     

栀子总苷对阿司匹林致胃黏膜损伤的保护作用

目的研究栀子总苷(TGZ)对阿司匹林所致急性胃黏膜损伤(AGML)的保护作用.方法采用阿司匹林ig诱导大鼠AGML模型.观察TGZ 140、70、35 mg/kg 3个剂量组和对照组的AGML指数,并同时检测胃黏膜局部血流量(GMBF)及血浆超氧化物歧化酶(SOD)活性和丙二醛(MDA)含量. 结果 TGZ用药组的AGML指数较模型对照组显著降低,GMBF较模型对照组明显增加;TGZ可明显提高血浆中SOD活性,降低其MDA含量.结论 TGZ 对阿司匹林所致AGML有明显的保护作用,其作用机制可能与增加胃黏膜血流及抗氧化作用有关.     

小肠三叶因子保护胃黏膜促进溃疡愈合的实验研究

目的:研究基因重组人小肠三叶因子(recombinant human intestinal trefoil factor , rhITF)促进慢性胃溃疡的愈合、保护胃黏膜抵抗多种损伤的作用及其机制.方法:(1) 急性损伤方法:用乙醇,阿司匹林,应激和幽门结扎诱发胃黏膜损伤,用Guth法测定损伤指数.(2)慢性溃疡产生法:用50%(质量分数)乙酸接触胃体部桨膜面.损伤后第2天开始经口灌 rhITF 11 d,第12天麻醉下测定胃黏膜面血流量(GMBF),取胃液测定胃酸排除量,检查溃疡指数、胃黏膜氨基己糖和一氧化氮浓度,检测溃疡底部一氧化氮合酶iNOS mRNA的表达.结果: rhITF有保护胃黏膜抗急性损伤的作用,在应激诱发的损伤中,胃黏膜糖蛋白含量增加.rhITF促进慢性胃溃疡的愈合,治疗组和对照组比较,溃疡指数和胃酸排除量明显减少(P<0.05),GMBF、Hex和NO含量及iNOS mRNA表达增加(P<0.05).结论:rhITF 保护胃黏膜可能和胃黏膜黏液糖蛋白增加有关.rhITF促进慢性胃溃疡愈合,其机制可能增加Hex含量和GMBF,抑制胃酸,刺激 iNOS的表达.     

Clinical Observation in 86 Cases of Acne Vulgaris Treated with Compound Oldenlandis Mixture

86 cases of acne vulgaris were treated with Fu Fang She She Cao He Ji (复方蛇舌草合剂 CompoundPrepared from Chinese Angelica and Flavescent Sophora Root) as the controls, to observe the therapeuticeffect of the former. The results showed that the cure plus markedly effective rate was 73.26% in thetreatment group, and 47.06% in the control group, with a significant difference in the cure plus markedlyeffective rate between the two groups (P＜0.01), and also in the total effective rate between the two groupssignificant (P＜0.05). It may be concluded that the Compound Oldenlandis Mixture is a better agent for theillness.     

大鼠孤束核在电针保护应激性胃黏膜损伤中的作用

目的探讨大鼠孤束核（NTS）在电针（EA）保护应激性胃黏膜损伤中的作用。方法将56只健康雄性SD大白鼠随机分为应激组、EA＋应激组、NTS电损毁组、NTS假损毁组。通过脑立体定向仪电损毁大鼠孤束核,采用束缚-浸水制备大鼠应激性胃溃疡模型,分别检测各组大鼠胃溃疡指数（UI）、胃黏膜血流量（GMBF）、胃液酸度。结果EA＋应激组UI明显减少,GMBF增加,胃酸分泌量减少。与应激组比较有显著性差异（P〈0.01,P〈0.001）。NTS电损毁组UI明显提高,GMBF减少,胃酸分泌量增加。分别与NTS假损毁组和EA＋应激组比较,差异均有显著性（P〈0.05或P〈0.001）。结论孤束核参与了电针足三里穴抗大鼠应激性胃黏膜损伤作用过程。     

胃炎消对胃癌癌前病变的作用机理探讨

【目的】探讨胃炎消(主要由太子参、田七、莪术、白花蛇舌草、生甘草等组成)逆转胃癌癌前病变(PLGC)的作用机制。【方法】采用链霉素抗生物素蛋白—过氧化酶(LSAB)免疫组化法,检测胃炎消治疗组及维酶素对照组共35例胃癌癌前病变患者治疗前后细胞周期素依赖性激酶(CDK_4)、增殖细胞核抗原(PCNA)和Ki-67的蛋白表达。【结果】CDK_4蛋白在PLGC的阳性率普遍较高,与正常空白对照组比较无显著性差异(P>0.05),两组治疗前后比较均无显著性差异(P>0.05);PCNA和Ki-67抗原的蛋白表达阳性率随着胃粘膜病变的进展而递增,治疗后胃炎消治疗组的阳性表达显著减少(P<0.05),维酶素对照组无明显变化(P>0.05)。【结论】胃炎消有抑制PLGC细胞过度增殖的作用,对CDK_4的蛋白表达无明显影响。     

电针足三里穴对胃粘膜保护作用的机制研究

[目的]探讨电针足三里穴对胃粘膜的保护作用机制。[方法]将20只狗随机分为空白对照组、非经非穴组、上巨虚组、足三里组（每组5只）。采用激光多普勒血流仪连续监测狗胃粘膜血流量的变化，同步测定血浆及胃粘膜组织中降钙素基因肽（CGRP）含量，并观察其变化规律。[结果]电针足三里穴可使狗胃粘膜血流量增加（与针刺前比P＜0.05或P＜0.01），使血浆和胃体粘膜中的CGRP含量增加（P＜0.05或P＜0.01)；而针刺上巨虚穴有同样的作用趋向，但未显示统计学意义；针刺非经非穴组未见这一变化。[结论]说明电针足阳明胃经穴位，尤其电针足三里穴可以改善胃粘膜的血流量，这种改善可能与针刺影响血浆和胃粘膜的CGRP含量升高有关，这可能也是电针足三里可以对胃粘膜起保护作用的机制之一。     

三七不同部位提取物体外抗氧化功效研究

目的:研究三七不同部位提取物的抗氧化功效,为三七化妆品原料的开发提供实验依据.方法:采用超氧阴离子自由基清除活性实验及羟自由基清除活性实验检测三七根、茎、叶、花提取物对超氧阴离子自由基及羟自由基的清除活性,依据自由基清除率计算半抑制浓度(inhibitory concentration 50,IC50).采用H2O2诱...     

Clinical Observation in 31 Cases of Chronic Bronchitis at Remission Stage Treated with Bufei Keli

To observe the therapeutic effects of a Chinese drug Bufei Keli (补肺颗粒 granules for invigorating thelung) in the treatment of chronic bronchitis at remission stage, 62 cases were randomly divided into aThe results turned out to be that the short-term clinically controlled and markedly effective rate was77.42% and the long-term relapse-resisting markedly effective rate was 74.2% in the treatment group,which were obviously higher than 45.16% and 38.71% respectively in the control group (P＜0.05). And theincrease in contents of SOD and CD3 and the decrease in LPO content in the treatment group were alsobigger than that in the control group (P＜0.01). It is therefore concluded that Bufei Keli can improve qideficiency syndrome and raise the immunity of patients with chronic bronchitis, hence its effect ofresisting relapse of chronic bronchitis.     

3-氧-乙酰-11-脱氧甘草次酸铝抗大鼠实验性胃溃疡作用机制

目的　探讨 3-氧 -乙酰 - 11-脱氧甘草次酸铝 (aluminum 3-oxo -acetyl- 11-deoxogly cyrrhetinate,ADA)对实验性大鼠胃溃疡的保护作用机制。 方法　采用Shay结扎法、醋酸法复制大鼠胃溃疡模型 ,分别测定给药后胃粘液PGE2 含量及胃粘膜血流量 (GMBF) ,并对结果进行统计分析。结果　ADA5 0mg·kg-1,10 0mg·kg-1与对照组相比 ,能显著增加胃内游离粘液和胃壁粘液量及胃壁内PGE2 含量(P <0 .0 1)。连续以ADA灌胃能显著增加胃粘膜血流量 (P <0 .0 1)。结论　ADA的抗溃疡作用与增加胃粘液量 ,促进PGE2 分泌及增加GMBF有关     

Clinical Observation on the Method of Supplementing Qi, Clearing away Heat and Promoting Blood Circulation for Treating 53 Cases of Gastritis Related to Pyrolic Helicobacterium

According to the clinical experience of professor Shan Zhaowei (单兆伟), the author has successfully developed Qingyou Yangwei Capsule (清幽养胃胶囊capsules for eliminating pyrolic Helicobacterium and nourishing the stomach) for treating the gastritis. Clinical research has shown that the capsule has a good curative effect on chronic gastritis related to pyrolic Helicobacterium. Among the 53 cases in the treatment group, clinical observation showed cure in 6 cases, obvious effect in 18 cases, effect in 24 cases, no effect on 5 cases, with a total effective rate of 90.5%. Of the 50 cases in the control group, cure was found in 5 cases, obvious effect in 13 cases, effect in 20 cases, no effect in 12 cases, the total effective rate being 76%. The total effective rate in the treatment group was higher than that in the control group. The rate of eliminating pyrolic Helicobacterium in the treatment group was 66.04%, similar to that in the control group. In a follow-up visit 6 months later, the recurrence rate in the treatment group was 13.33%, obviously lower than that of 41.66% in the control group.     

Effects of Huang Qi Wu Wu Decoction on Plasma Proteins in 70 Cases of Chronic Pulmonary Heart Disease

Simple immune agar diffusion test was used to assay the contents of 12 plasma proteins in 70 cases ofchronic pulmonary heart disease treated by Huang Qi Wu Wu Decoction(黄芪五物汤),with theother 70 cases who were not given Huang Qi Wu Wu Decoction as the control group.The totalclinical effective rate in the treatment group was 90.0%,while that in the control group was 75.7%,with a statistically significant difference between the two groups(P<0.05).In the treatment group,thelevels of prealbumin,transferrin and fibronectin elevated obviously after treatment,and the contentsof C-reactive protein,ceruloplasmin,haptoglobin,α_1-antitrypsin and oh-acid glycoprotein decreasedmarkedly(P<0.01).In the control group,only the levels of ceruloplasmin and C-reactive proteindecreased significantly(P<0.05).It is shown that Huang Qi Wu Wu Decoction may enhance thetherapeutic effects for pulmonary heart disease,regulate the metabolism of plasma proteins,andimprove the life quality of the patients.